Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) for Thromboembolic Prevention, Are They Safe in Congenital Heart Disease? Results of a Worldwide Study

International Journal of Cardiology - Ireland
doi 10.1016/j.ijcard.2019.06.014

Related search